These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 32165595

  • 1. Circulating MiR-29a, Possible Use as a Biomarker for Monitoring IgA Nephropathy.
    Hu H, Wan Q, Li T, Qi D, Dong X, Xu Y, Chen H, Liu H, Huang H, Wei C, Zhou W, Jiang S, Mo Z, Liao F, Xu Q, He Y.
    Iran J Kidney Dis; 2020 Mar; 14(2):107-118. PubMed ID: 32165595
    [Abstract] [Full Text] [Related]

  • 2. Blood TGF-β1 and miRNA-21-5p levels predict renal fibrosis and outcome in IgA nephropathy.
    Bharti N, Agrawal V, Kamthan S, Prasad N, Agarwal V.
    Int Urol Nephrol; 2023 Jun; 55(6):1557-1564. PubMed ID: 36648741
    [Abstract] [Full Text] [Related]

  • 3. NLRC5: potential novel non-invasive biomarker for predicting and reflecting the progression of IgA nephritis.
    Chen Y, Li H, Xiao C, Zeng X, Xiao X, Zhou Q, Xiao P.
    J Transl Med; 2018 Nov 19; 16(1):317. PubMed ID: 30453994
    [Abstract] [Full Text] [Related]

  • 4. Serum immunoglobulin A/C3 ratio predicts progression of immunoglobulin A nephropathy.
    Zhang J, Wang C, Tang Y, Peng H, Ye ZC, Li CC, Lou TQ.
    Nephrology (Carlton); 2013 Feb 19; 18(2):125-31. PubMed ID: 23134230
    [Abstract] [Full Text] [Related]

  • 5. Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy.
    Yoon SY, Kim JS, Jung SW, Kim YG, Hwang HS, Moon JY, Lee SH, Seo JW, Seok J, Tae D, Jeong K.
    Sci Rep; 2023 Oct 11; 13(1):17201. PubMed ID: 37821628
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. High Neutrophil-To-Lymphocyte Ratio Is an Independent Risk Factor for End Stage Renal Diseases in IgA Nephropathy.
    Wang S, Dong L, Pei G, Jiang Z, Qin A, Tan J, Tang Y, Qin W.
    Front Immunol; 2021 Oct 11; 12():700224. PubMed ID: 34456912
    [Abstract] [Full Text] [Related]

  • 9. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
    Dong J, Peng T, Gao J, Jia X, Yan G, Wang Y.
    BMC Immunol; 2018 Jun 20; 19(1):18. PubMed ID: 29925312
    [Abstract] [Full Text] [Related]

  • 10. Correlation analysis between expression of histone deacetylase 6 and clinical parameters in IgA nephropathy patients.
    Hu Y, Shang M, Shi Y, Tao M, Yuan W, Tang L, Ma X, Cui B, Chen H, Zhou X, Zhuang S, Liu N.
    Ren Fail; 2021 Dec 20; 43(1):684-697. PubMed ID: 33896334
    [Abstract] [Full Text] [Related]

  • 11. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
    Tian S, Yang X, Luo J, Guo H.
    Int Immunopharmacol; 2020 Nov 20; 88():106896. PubMed ID: 33182045
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum miR-192 Is Related to Tubulointerstitial Lesion and Short-Term Disease Progression in IgA Nephropathy.
    Fan Q, Lu R, Zhu M, Yan Y, Guo X, Qian Y, Zhang L, Dai H, Ni Z, Gu L.
    Nephron; 2019 Nov 20; 142(3):195-207. PubMed ID: 30808829
    [Abstract] [Full Text] [Related]

  • 14. Plasma microRNA signature of patients with IgA nephropathy.
    Wu J, Zhang H, Wang W, Zhu M, Qi LW, Wang T, Cheng W, Zhu J, Shan X, Huang Z, Zhang L, Chen Y, Sun B, Zhao X, Qian J, Zhu W, Zhou X, Xing C.
    Gene; 2018 Apr 05; 649():80-86. PubMed ID: 29459010
    [Abstract] [Full Text] [Related]

  • 15. Vitamin D deficiency may predict a poorer outcome of IgA nephropathy.
    Li XH, Huang XP, Pan L, Wang CY, Qin J, Nong FW, Luo YZ, Wu Y, Huang YM, Peng X, Yang ZH, Liao YH.
    BMC Nephrol; 2016 Nov 02; 17(1):164. PubMed ID: 27806690
    [Abstract] [Full Text] [Related]

  • 16. Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy.
    Chen P, Shi SF, Qu Z, Zhao N, Xie XF, Lv JC, Liu LJ, Zhang H.
    Ren Fail; 2018 Nov 02; 40(1):213-218. PubMed ID: 29619862
    [Abstract] [Full Text] [Related]

  • 17. Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy.
    Lundberg S, Lundahl J, Gunnarsson I, Sundelin B, Jacobson SH.
    Nephrol Dial Transplant; 2012 May 02; 27(5):1916-23. PubMed ID: 21940483
    [Abstract] [Full Text] [Related]

  • 18. The Value of Serum IgA in the Diagnosis, Clinical and Pathological Evaluation of Patients with IgA Nephropathy Found During Physical Examination in China.
    Ren L, Zhang C, Pan Y, Sun J.
    Clin Lab; 2019 Dec 01; 65(12):. PubMed ID: 31850707
    [Abstract] [Full Text] [Related]

  • 19. Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients.
    Zittema D, van den Brand JA, Bakker SJ, Wetzels JF, Gansevoort RT.
    Nephrol Dial Transplant; 2017 Jan 01; 32(suppl_1):i146-i153. PubMed ID: 28057871
    [Abstract] [Full Text] [Related]

  • 20. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
    Rhee H, Shin N, Shin MJ, Yang BY, Kim IY, Song SH, Lee DW, Lee SB, Kwak IS, Seong EY.
    Korean J Intern Med; 2015 May 01; 30(3):354-61. PubMed ID: 25995666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.